Merck Biopharma Overview
- Status
-
Acquired/Merged
- Employees
-
10,001
- Latest Deal Type
-
M&A
- Financing Rounds
-
3
- Investments
-
11
Merck Biopharma General Information
Description
Operator of bio pharmaceutical company. The company specializes in the manufacturing of cancer and cardiovascular drugs.
Contact Information
Corporate Office
- Frankfurter Straße 250
- 64293 Darmstadt
- Germany
Corporate Office
- Frankfurter Straße 250
- 64293 Darmstadt
- Germany
Merck Biopharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Merck Biopharma Comparisons
Industry
Financing
Details
Merck Biopharma Competitors (17)
One of Merck Biopharma’s 17 competitors is Lonza Group, a Corporation company based in Basel, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Lonza Group | Corporation | Basel, Switzerland | ||||
| Vetter Pharma | Private Debt Financed | Ravensburg, Germany | ||||
| Eisai | Corporation | Tokyo, Japan | ||||
| Sandoz | Corporation | Basel, Switzerland | ||||
| BSP Pharmaceuticals | Corporation | Latina Scalo, Italy |
Merck Biopharma Signals
Merck Biopharma Investments & Acquisitions (11)
Merck Biopharma’s most recent deal was a Grant with VAR2 Pharma for . The deal was made on 06-Jul-2020.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| VAR2 Pharma | 06-Jul-2020 | Grant | Drug Discovery | ||
| HQS Quantum Simulations | 01-Jan-2018 | Grant | Business/Productivity Software | ||
| GQ Bio Therapeutics | 15-Dec-2016 | Grant | Drug Discovery | ||
| Fresh Strips | 22-Sep-2016 | Grant | Other Containers and Packaging | ||
| Shift.ms | 01-Jan-2015 | Grant | Social Content |
Merck Biopharma Exits (6)
Merck Biopharma’s most recent exit was on 15-Dec-2016 from GQ Bio Therapeutics. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| GQ Bio Therapeutics | 15-Dec-2016 | Completed |
|
||
| Fresh Strips | 22-Sep-2016 | Completed |
|
||
| Neviah Genomics | 25-Jun-2012 | Completed |
|
||
| Merck Serono & BioMarin Pharmaceutical (Kuvan Rights) | 01-Jan-2005 | Completed |
|
||
| Merck Serono & BioMarin Pharmaceutical (Kuvan Rights) | Corporate Asset Purchase | Completed |
Merck Biopharma FAQs
-
Where is Merck Biopharma headquartered?
Merck Biopharma is headquartered in Darmstadt, Germany.
-
What is the size of Merck Biopharma?
Merck Biopharma has 10,001 total employees.
-
What industry is Merck Biopharma in?
Merck Biopharma’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Merck Biopharma a private or public company?
Merck Biopharma is a Private company.
-
What is Merck Biopharma’s current revenue?
The current revenue for Merck Biopharma is .
-
How much funding has Merck Biopharma raised over time?
Merck Biopharma has raised $14.8B.
-
Who are Merck Biopharma’s competitors?
Lonza Group, Vetter Pharma, Eisai, Sandoz, and BSP Pharmaceuticals are some of the 17 competitors of Merck Biopharma.
-
When was Merck Biopharma acquired?
Merck Biopharma was acquired on 07-Feb-2007.
-
Who acquired Merck Biopharma?
Merck Biopharma was acquired by Merck.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process